OC-0068: A methodological approach to reporting corrected small field relative outputs  by Cranmer-Sargison, G. et al.
S26  2nd ESTRO Forum 2013	
Results: Independent of filtering all investigated detectors showed 
qualitatively the same behavior over the investigated range of fields 
for all energies. SFD, EFD and the air filled ionization chambers 
agreed within 1% for field sizes equal or larger than 2.4x2.4cm². 
Moreover, the readings of SFD and EFD agreed within 1% of all 
investigated field sizes and deviated by less than 4% compared to the 
reference detector. PFD and MicroLion showed a systematic over 
response by more than 1%for field sizes smaller than 4.2x4.2cm². For 
the smallest field size of 0.6x0.6cm² the output factors measured with 
the CC13 and IC10 decrease rapidly by about 20% compared the CC01 
due to their comparatively large volume. For the CC04, PinPoint 14 
and PinPoint 16 an under response of up to 10% was observed, 
whereas MicroLion and PFD showed an over response of up to 14% and 
5%, respectively. 
 
Conclusions: No substantial influence of filtering on the readings of 
the investigated detectors was found. With exception of the CC13 and 
IC10 chambers all investigated detectors might be used for small field 
dosimetry. However, appropriate detector correction factors need to 
be determined. 
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Purpose/Objective: With properties such as water-equivalence, high 
spatial resolution and energy independence, plastic scintillation 
detectors (PSDs) have been shown to be excellent dosimeters for 
radiation therapy applications. In this work, our purpose is to perform 
a thorough benchmarking of the first commercial PSD, the Exradin W1 
(Standard Imaging, Middleton, USA), to evaluate its performance in 
terms of precision and accuracy in a wide range of situations. 
Materials and Methods: The Exradin W1 is a commercial PSD 
comprising a miniature scintillator probe (< 2.3 mm3 sensitive 
volume), a clear optical fiber and a photodiode enclosed in a shielded 
housing. The electric signal produced by the photodiode is read by a 
dual-channel electrometer. In a first study, the basic properties of the 
Exradin W1 were evaluated. Precision and signal-to-noise ratios were 
determined as a function of delivered doses. Stem effect, which was a 
well-known problem in PSD was characterized in depth. The effect of 
the bending radius of the optical fiber was determined as well as the 
impact of stray radiation on the photodiode housing. Finally, the 
robustness of the calibration and its stability over time was assessed. 
In a second study, clinically relevant measurements were performed. 
Depth dose curves, profiles, out-of-field measurements as well as 
intensity modulated radiation therapy (IMRT) output measurements 
were made. Photon irradiations were made with Cobalt-60 and high-
energy linear accelerators. Electron irradiations were made with 
energies between 6 MeV and 18 MeV. Measurements were compared 
with data acquired with ion chambers. 
Results: Detector precision was excellent, and the measured 
uncertainty was typically below 0.4% for repeated measurements. 
Day-to-day reproducibility was 0.6% thus showing the high stability of 
the system. Nevertheless, the current generated by the photodiode is 
typically an order of magnitude lower than the current produced by 
an ion chamber. Bending the optical fiber had measurable effects 
starting at a bending radius of 7 cm (1% loss). Up to 8% losses were 
measured for a bending radius of 3 cm. After following the calibration 
procedure given by the manufacturer, no measurable stem effect was 
observed. Accuracy of the clinically relevant measurements was high 
with less than 0.6% discrepancy between the PSD and the reference 
data. Sample data for depth dose curves is shown in Figure 1. 
Measurements of out-field doses were also in good agreement (better 
than 2%) with ion chamber data even though the PSD signal intensity 
was low. 
 
  
Conclusions: The W1 scintillator has been validated through an 
extensive set of measurements. Although the signal is small the 
precision and accuracy are high, thus making this detector ideal for 
radiation therapy measurements and monitoring. In future work, we 
will investigate the use of this detector for specific applications such 
as radiosurgery and in vivo measurements. 
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Purpose/Objective: The clinical viability of applying small field 
central axis relative output correction factors requires standardization 
in measurement, a mechanism by which dosimetric values can be 
correlated to the actual delivered field size and assessing the 
suitability of Monte Carlo (MC) correction factor data for use across a 
population of linacs. Each is addressed in this work. 
Materials and Methods: Measurements were made at a nominal 6 MV 
on multiple Varian iX linacs at two different institutions using the SFD 
and T60017 un-shielded diodes. Detector specific output ratios (ORdet) 
were calculated with respect to a square jaw collimated field of side 
3.0 cm for square field sizes of side 1.0, 0.9, 0.8, 0.7, 0.6 and 0.5 cm. 
During each measurement session five central axis output readings 
and five profile measurements were made for each field before 
changing the collimation to the next field size. This was repeated 
during three independent experimental sessions. The standard 
experimental uncertainty was calculated for both ORdet and field 
width, defined as the FWHM at 50% in A (in-plane) and B (x-plane). An 
effective field size, defined as FSeff = (A·B)½, was calculated using the 
measured field widths and is presented as a field size metric for 
reporting measured relative output in small fields. The 
appropriateness of using FSeff, and linear interpolation between MC 
simulated ORdet data at the nominal field sizes, was investigated. FSeff 
was then used to linearly interpolate between the MC calculated 
correction factors to account for the detector specific over-response 
in small fields. 
Results: In general, one cannot assume jaw collimated small field size 
constancy across apopulation of linacs. A clear example would be the 
actual field widths measured on two of linacs used in this study. For a 
nominal 0.5 cm x 0.5 cm jaw collimated field the measured sizes were 
0.43 cm x 0.53 cm and 0.45 cm x 0.46cm. FSeff for each was 0.477 cm 
and 0.454 cm respectively. For these cases linear interpolation 
between MC calculated ORdet at 0.45 cm and 0.50 cm validated the 
electron source FWHM for each linac to be 0.10 cm and 0.11 cm 
respectively. Correction factors were then found for each detector 
through linear interpolation between the corresponding correction 
data. 
Conclusions: FSeff is a conceptually simple method for reporting 
measured relative output to the actual field size, yet just such a 
metric clearly standardizes the methodology of reporting delivered 
field size across a population of linacs. In addition, using a linear 
interpolation method between tabulated ORdet and corretion factors is 
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consistent with standard clinical practice. However, to facilitate 
linear interpolation between MC calculated values the simulated field 
sizes should be increment in steps of 0.05 cm. 
 
 PROFFERED PAPERS: RTT 1: GEOMETRIC UNCERTAIN-
TIES: A MULTIFACTORAL PROBLEM?  
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Purpose/Objective: Total marrow (and lymph nodes) irradiation (TMI 
and TMLI) by volumetric modulated arc therapy (VMAT) was shown to 
be feasible. Many arcs with different isocenters are required to best 
cover the hematopoietic or lymphoid tissues target and to spare the 
neighbour healthy tissues according with ALARA principle. The direct 
consequence is the necessity of overlapping regions between 
neighbour arcs. In this study we evaluated the dosimetric 
consequences of inaccurate isocenter positioning during the treatment 
of TMI and TMLI treatments using volumetric modulated arc therapy 
(VMAT). 
Materials and Methods: Two plans were randomly selected from the 
internal database of patients treated with TMI or TMLI using VMAT 
technique (one per case). Dose prescription was 12Gy to target in 6 
fractions, 2 times per day for TMI, and 2 Gy in single fraction for TMLI. 
All body bones were defined as PTV. For TMLI, treatments lymph 
nodes and spleen were considered too. Ten arcs on 5 isocenters (2 
arcs for isocenter) were used to cover the upper part of PTV (i.e. from 
cranium to middle femurs). For each plan, two series of random shifts 
(between -3 to +3 and -5 to +5 mm) were applied in each single 
direction (Left-Right (LR), Anterior-Posterior (AP), Cranial-Caudal 
(CC)) for each isocenter (total of 60 random shifts) simulating 
involuntary patient motion during the treatment. The shifted plans 
were recalculated with the same monitor units and compared to the 
reference ones in terms of target coverage (mean dose to PTV, V80% 
(i.e. %volume receiving at least 80% of the prescription dose), V90%, 
V95%, V110%, Homogeneity index HI=(D2%-D98%)) and body in terms of 
mean dose and max dose (i.e. D10cm3). 
Results: No substantial differences (<0.5%) were found for mean dose 
and V80% to PTV, and mean dose to body between the reference plans 
and the ones randomly shifted in the 3 directions. For all other 
parameters there was a worsening with random shift increasing. In 
particular the differences were <1% and <4% in LR and AP in case of, 
respectively, 3 mm and 5 mm random shifts, but became higher for CC 
shifts. In detail, V95% decreased from 95% to 88% in case of TMI and 5 
mm shift; V110% passed from 7.4% to 11.0% and 11.6% for TMI with 3 
and 5 mm shifts. Homogeneity index enlarged of 4% and 7% for TMLI 
case. Maximum dose to body increased of 7% and 19% for TMLI case. 
Conclusions: The correct isocenter repositioning of TMI-TMLI patients 
is fundamental, in particular in CC direction. A dedicated 
immobilization system was developed in our center to best immobilize 
the patient.  
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Purpose/Objective: The purpose of this study was to compare the 
setup accuracy of two different immobilization systems for 
radiotherapy at head and neck region. 
Materials and Methods: 36 head and neck patients were recruited in 
this study, of which is composed by patients using the Orfit 
immobilization system (n=15) and patients using the CIVCO 
immobilization system (n=21). A total of 911 sets of Megavoltage 
Computed Tomography (MVCT) images were obtained. Prior to each 
daily treatment, a set of MVCT images was acquired and fused with 
the planning CT images. From the image registration result, the 
detected setup corrections of three translational deviations 
(longitudinal, vertical and lateral) and the roll rotational deviations 
were recorded and analyzed. Systematic errors, random errors, and 
3D vectors were calculated and compared between the two 
immobilization systems. The sizes of the clinical target volume-
planning target volume (CTV-PTV) margins were also determined from 
the calculated systematic errors and random errors. 
Results: Calculated systematic errors, random errors, 3D vectors and 
CTV-PTV margins were demonstrated in Table 1. No significant 
difference was identified between the calculated systematic errors of 
Orfit and CIVCO immobilization systems (p>0.05). Orfit immobilization 
system had a significantly smaller random errors in the translation 
deviations of lateral, longitudinal and vertical directions with the 
differences of 0.3mm, 0.5mm and 0.1mm respectively (p<0.05) . 
There was no significant difference in roll rotational deviation found 
between Orfit and CIVCO immobilization systems (p>0.05). The 3D 
vector mean of the Orfit immobilization system was found 
substantially smaller (p<0.05) than which of CIVCO. The calculated 
CTV-PTV margins showed that Orfit system required 1.2mm and 
2.4mm smaller margins in the lateral and longitudinal direction, 
respectively, when compared with CIVCO. 
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 Σ= systematic errors, σ= random errors, lat = lateral, lng = 
longitudinal, vrt = vertical, roll = roll  
CTV-PTV margins calculated by using formula of van Herk et al : 
CTV-PTV margin M=2.5Σ (Systematic error) + 0.7σ (random error). 
Statistical significant results were represented by underlined 
numbers. 
Conclusions: The random errors in translation deviations were found 
to be less significant in the Orfit immobilization system, which 
indicates that it gives smaller daily setup variations when compared 
with CIVCO. The CTV-PTV margins calculated in lateral and 
longitudinal were also smaller in the Orfit system. 
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Purpose/Objective: Small cell lung cancer(SCLC) is a tumour site 
considerably influenced by tumour changes during delivery of chemo-
radiotherapy. In this study we have compared tumour change across 
three methods. 
Materials and Methods: A total of 37 SCLC pts treated with on-line 
image registration during 2010-2011 were included. The treatment 
dose was 45Gy in 30.fractions(fr), twice-daily (31pts) or 50Gy in 25.fr, 
once-daily (6pts). In addition the pts were treated with 4-6 cycles of 
chemotherapy (carboplatin/cisplatin and etoposide). The gross tumour 
volume at tumour site(GTV-T) was delineated at a pre-treatment 4D 
CT scan. The pts were treated according to 3D CBCT bony anatomy 
registration. Each scans were retrospectively reviewed for every 6th fr. 
Kappa(k) statistics with a dichotomous registration of tumour-change 
or not was used for evaluation of the inter-tester agreement between 
visual/algorithm and visual/doctor assessment. Paired T-test statistics 
on log-transformed normal distributed data was used for evaluation of 
GTV at fr 30 by doctor and algorithm. Tumour change was obtained by 
deformable propagation of the GTV using the B-spline algorithm in 
SmartAdapt(Varian Medical Systems). The calculations were based on 
the assumption: a registration of tumour-change was defined as >5ml 
or 10-15% changes of the tumour, depending of the tumour size, 
compared to the planning CTscan. 
